(1)
A Study of the Safety and Efficacy of Alternate Day Vs. Daily Rosuvastatin Dosing in Hypercholesterolemia Patients at Tertiary Care Hospital. J Nobel Med Coll 2021, 10 (2), 33-37. https://doi.org/10.3126/jonmc.v10i2.41768.